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3-Phosphoinositide-dependent protein kinase-1 (PDK1):
structural and functional homology with the Drosophila
DSTPK61 kinase
Dario R. Alessi*, Maria Deak*, Antonio Casamayor*, F. Barry Caudwell*,
Nick Morrice*, David G. Norman†, Piers Gaffney‡, Colin B. Reese‡, Colin N.
MacDougall§, Diane Harbison§, Alan Ashworth¶ and Mary Bownes§
Background: The activation of protein kinase B (PKB, also known as c-Akt) is
stimulated by insulin or growth factors and results from its phosphorylation at
Thr308 and Ser473. We recently identified a protein kinase, termed PDK1, that
phosphorylates PKB at Thr308 only in the presence of lipid vesicles containing
phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) or
phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2).
Results: We have cloned and sequenced human PDK1. The 556-residue
monomeric enzyme comprises a catalytic domain that is most similar to the
PKA, PKB and PKC subfamily of protein kinases and a carboxy-terminal
pleckstrin homology (PH) domain. The PDK1 gene is located on human
chromosome 16p13.3 and is expressed ubiquitously in human tissues. Human
PDK1 is homologous to the Drosophila protein kinase DSTPK61, which has
been implicated in the regulation of sex differentiation, oogenesis and
spermatogenesis. Expressed PDK1 and DSTPK61 phosphorylated Thr308 of
PKBα only in the presence of PtdIns(3,4,5)P3 or PtdIns(3,4)P2. Overexpression
of PDK1 in 293 cells activated PKBα and potentiated the IGF1-induced
phosphorylation of PKBα at Thr308. Experiments in which the PH domains of
either PDK1 or PKBα were deleted indicated that the binding of
PtdIns(3,4,5)P3 or PtdIns(3,4)P2 to PKBα is required for phosphorylation and
activation by PDK1. IGF1 stimulation of 293 cells did not affect the activity or
phosphorylation of PDK1.
Conclusions: PDK1 is likely to mediate the activation of PKB by insulin or
growth factors. DSTPK61 is a Drosophila homologue of PDK1. The effect of
PtdIns(3,4,5)P3/PtdIns(3,4)P2 in the activation of PKBα is at least partly
substrate directed.
Background
Protein kinase B (PKB) [1] or Rac protein kinase [2] is the
cellular homologue of a viral oncogene product v-Akt [3]
and has therefore also been termed c-Akt. The current
interest in PKB stems, firstly, from the observation that it is
activated rapidly in response to insulin and growth factors
and that the activation is prevented by inhibitors of phos-
phoinositide (PtdIns) 3-kinase [4–6] and, secondly, from
the finding that PKB isoforms are overexpressed in a signif-
icant percentage of ovarian, pancreatic [7,8] and breast
cancer cells [2]. More recently, it has been found that PKB
provides a survival signal that protects cells from apoptosis
induced by ultraviolet radiation, by the withdrawal of the
survival factor insulin-like growth factor-1 (IGF1) from neu-
ronal cells, by the withdrawal of serum factors while c-myc is
expressed artificially, and by detachment of cells from the
extracellular matrix [9–12]. The activation of PKB by gene
amplification (and other mechanisms) may, therefore, con-
tribute to the generation of malignancies that are able to
flourish in the absence of extracellular survival signals [13]. 
Only two of the physiological substrates for PKB have so far
been identified. PKB appears to mediate the insulin-
induced inhibition of glycogen synthase kinase-3 (GSK3);
this is thought to underlie the insulin-induced dephospho-
rylation and activation of glycogen synthase [14] and
protein synthesis initiation factor eIF-2B [15] that con-
tributes to the stimulation of glycogen and protein synthesis
by insulin [16]. PKB also appears to mediate the insulin-
induced activation of the cardiac isoform of 6-phospho-
fructo-2-kinase, which is likely to underlie the stimulation
of cardiac glycolysis by this hormone [17,18]. In transfec-
tion-based experiments, PKB also mimics two further
actions of insulin, namely the activation of p70 S6 kinase [5]
Addresses: *MRC Protein Phosphorylation Unit,
Department of Biochemistry, University of Dundee,
Dundee DD1 4HN, UK. †Department of
Biochemistry, University of Dundee, Dundee DD1
4HN, UK. ‡Department of Chemistry, Kings College,
Strand, London WC2R 2LS, UK. §Institute of Cell &
Molecular Biology, Darwin Building, Mayfield Road,
Edinburgh EH9 3JR, UK. ¶CRC Centre for Cell and
Molecular Biology, Chester Beatty Labs, The
Institute of Cancer Research, Fulham Road, London
SW3 6JB, UK.
Correspondence: Dario R. Alessi 
Email: dralessi@bad.dundee.ac.uk
Received: 19 June 1997
Revised: 22 July 1997
Accepted: 22 July 1997
Published: 18 September 1997
Current Biology 1997, 7:776–789
http://biomednet.com/elecref/0960982200700776
© Current Biology Ltd ISSN 0960-9822
and the enhancement of glucose uptake that results from
the translocation of GLUT4 from an intracellular compart-
ment to the plasma membrane [19]. 
The activation of PKB induced by insulin or IGF1 results
from its phosphorylation at Thr308 and Ser473 and the
phosphorylation of both of these residues in vivo is abol-
ished by wortmannin, an inhibitor of PtdIns 3-kinase [20].
These findings suggested that the protein kinases that
phosphorylate PKB at Thr308 and Ser473 would be effec-
tive in activating PKB only in the presence of phos-
phatidylinositol 3,4,5 trisphosphate (PtdIns(3,4,5)P3), the
product of the PtdIns 3-kinase reaction. This proved to be
the case when we reported recently the purification from
skeletal muscle and initial characterisation of a protein
kinase that phosphorylates PKB at Thr308 [21]. This
enzyme activates PKBα only in the presence of either
PtdIns(3,4,5)P3 or PtdIns(3,4)P2 and has, therefore, been
termed 3-phosphoinositide-dependent protein kinase-1
(PDK1). PDK1 activity itself is unaffected by wortmannin,
indicating that it is not a member of the PtdIns 3-kinase
family [21]. 
In order to elucidate the role of PDK1 in vivo it was clearly
essential to first determine the structure of the enzyme
and the mechanism by which PtdIns(3,4,5)P3 or
PtdIns(3,4)P2 allows PDK1 to phosphorylate PKB. In this
paper, we report the cloning, sequencing and expression
of human PDK1 and demonstrate that the expressed
enzyme activates PKBα in vitro in an identical manner to
PDK1 purified from muscle. PDK1 also activates PKBα in
cotransfection experiments and potentiates the phos-
phorylation of Thr308 induced by IGF1. We demonstrate
that the binding of PtdIns(3,4,5)P3 or PtdIns(3,4)P2 to the
pleckstrin homology (PH) domain of PKBα is necessary
for PDK1 to phosphorylate and activate PKBα. Interest-
ingly, PDK1 was found to be structurally and functionally
homologous to the Drosophila protein kinase DSTPK61,
which has been implicated in the regulation of sexual
development in Drosophila (C.M., M. Todman and M.B.,
unpublished observations).
Results
Characterisation of PDK1 purified from rabbit skeletal
muscle
PDK1 was purified 500,000-fold from rabbit skeletal
muscle and about 2 µg of protein were isolated from 500 g
of tissue [21]. SDS–polyacrylamide gel electrophoresis of
the preparation revealed three proteins, two with molecular
masses of 85 kDa and 45 kDa and a diffuse band of
67–69 kDa. Each band was excised from the gel, digested
with trypsin and the resulting peptides chromatographed on
a C18 column and sequenced. This analysis revealed that
the 85 kDa and 45 kDa proteins were 6-phosphofructose 1-
kinase and the α-subunit of casein kinase II, respectively,
and that the 67–69 kDa band was likely to encode a
previously unknown protein kinase. Since purified casein
kinase II did not activate or phosphorylate a fusion protein
of PKBα with glutathione S-transferase (GST–PKBα; data
not shown), the 67–69 kDa protein was considered likely to
be PDK1. This was consistent with the observation that
PDK1 activity eluted from a gel filtration column with an
apparent mass of ~70 kDa (data not shown). Evidence to be
described below established this was indeed the case, and
for this reason the protein is hereafter termed PDK1. 
The human expressed sequence tag database dbEST was
interrogated using nine peptide sequences from the
67–69 kDa band, which identified 14 overlapping
sequences (Table 1) that together encode a novel protein
kinase. A PCR fragment corresponding to part of this
protein was generated from a human MCF7 cell line cDNA
library, and this was used to isolate a full-length clone from
the same library (see Materials and methods). The
nucleotide and deduced amino acid sequence of PDK1 is
shown in Figure 1. It contains all of the nine peptide
sequences that we obtained from the 67–69 kDa protein
from rabbit skeletal muscle without any amino acid
changes, indicating that the protein sequence is highly con-
served between mammals. The sequence encodes a 556-
residue protein, with a predicted molecular mass of
63.1 kDa. We expressed the PDK1 protein with a Myc
epitope tag in 293 cells (see below), the tagged protein
migrating as a 68–70 kDa band in SDS–polyacrylamide gel
electrophoresis. PDK1 antibodies that we have raised
recognise a 69 kDa band in 293 cell lysates (data not
shown). For this reason, and because the initiating methion-
ine lies in a good Kozak consensus sequence, the sequence
shown in Figure 1 is likely to represent the whole of PDK1. 
Human ESTs encoding PDK1 are derived from many
tissues (Table 1). Interestingly, the nucleotide sequence
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Table 1
GenBank accession numbers for PDK1 ESTs. 
Accession number Tissue from which EST derives
AA186323 HeLa cells
H97903 Melanocyte
AA018098 Retina
AA018097 Retina
AA019394 Retina
AA019393 Retina
N22904 Melanocyte
W94736 Fetal heart
EST51985 Gall bladder
N31292 Melanocyte
AA188174 HeLa cells
AA100210 Colon
R84271 Retina
AA121994 Pancreas
of PDK1 possessed 100% identity to the partial sequence
of a gene that has been mapped to a 700 kb region on
human chromosome 16p13.3 close to the genes responsi-
ble for polycystic kidney disease type 1 and tuberous scle-
rosis disease type 2 [22]. This gene is known to be
expressed as an 8 kb transcript in heart, brain, placenta,
lung, skeletal muscle, kidney and pancreas [22].
PDK1 is a human homologue of the Drosophila DSTPK61
protein kinase
The catalytic domain of PDK1 spans residues 84–341
(Figure 1) and contains all of the classical kinase subdo-
mains I–XI [23]. It is most similar to the subfamily of
protein kinases that include PKA (39% identity to the cat-
alytic domain), PKC (36% identity to the ζ isoform) and
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Figure 1
          CCGCTTCGGGGAGGAGGACGCTGAGGAGGCGCCGAGCCGCGCAGCGCTGCGGGGGAGGCGCCCGCGCCGACGCGGGGCCC
   1 ATGGCCAGGACCACCAGCCAGCTGTATGACGCCGTGCCCATCCAGTCCAGCGTGGTGTTATGTTCCTGCCCATCCCCATCAATGGTGAGG   90
   1  M  A  R  T  T  S  Q  L  Y  D  A  V  P  I  Q  S  S  V  V  L  C  S  C  P  S  P  S  M  V  R   30
  91 ACCCAGACTGAGTCCAGCACGCCCCCTGGCATTCCTGGTGGCAGCAGGCAGGGCCCCGCCATGGACGGCACTGCAGCCGAGCCTCGGCCC  180
  31  T  Q  T  E  S  S  T  P  P  G  I  P  G  G  S  R  Q  G  P  A  M  D  G  T  A  A  E  P  R  P   60
 181 GGCGCCGGCTCCCTGCAGCATGCCCAGCCTCCGCCGCAGCCTCGGAAGAAGCGGCCTGAGGACTTCAAGTTTGGGAAAATCCTTGGGGAA  270
  61  G  A  G  S  L  Q  H  A  Q  P  P  P  Q  P  R  K  K  R  P  E  D  F  K  F  G  K  I  L  G  E   90
 271 GGCTCTTTTTCCACGGTTGTCCTGGCTCGAGAACTGGCAACCTCCAGAGAATATGCGATTAAAATTCTGGAGAAGCGACATATCATAAAA  360
  91  G  S  F  S  T  V  V  L  A  R  E  L  A  T  S  R  E  Y  A  I  K  I  L  E  K  R  H  I  I  K  120
 361 GAGAACAAGGTCCCCTATGTAACCAGAGAGCGGGATGTCATGTCGCGCCTGGATCACCCCTTCTTTGTTAAGCTTTACTTCACATTTCAG  450
 121  E  N  K  V  P  Y  V  T  R  E  R  D  V  M  S  R  L  D  H  P  F  F  V  K  L  Y  F  T  F  Q  150
 451 GACGACGAGAAGCTGTATTTCGGCCTTAGTTATGCCAAAAATGGAGAACTACTTAAATATATTCGCAAAATCGGTTCATTCGATGAGACC  540
 151  D  D  E  K  L  Y  F  G  L  S  Y  A  K  N  G  E  L  L  K  Y  I  R  K  I  G  S  F  D  E  T  180
 541 TGTACCCGATTTTACACGGCTGAGATCGTGTCTGCTTTAGAGTACTTGCACGGCAAGGGCATCATTCACAGGGACCTTAAACCGGAAAAC  630
 181  C  T  R  F  Y  T  A  E  I  V  S  A  L  E  Y  L  H  G  K  G  I  I  H  R  D  L  K  P  E  N  210
 631 ATTTTGTTAAATGAAGATATGCACATCCAGATCACAGATTTTGGAACAGCAAAAGTCTTATCCCCAGAGAGCAAACAAGCCAGGGCCAAC  720
 211  I  L  L  N  E  D  M  H  I  Q  I  T  D  F  G  T  A  K  V  L  S  P  E  S  K  Q  A  R  A  N  240
 721 TCATTCGTGGGAACAGCGCAGTACGTTTCTCCAGAGCTGCTCACGGAGAAGTCCGCCTGTAAGAGTTCAGACCTTTGGGCTCTTGGATGC  810
 241  S  F  V  G  T  A  Q  Y  V  S  P  E  L  L  T  E  K  S  A  C  K  S  S  D  L  W  A  L  G  C  270
 811 ATAATATACCAGCTTGTGGCAGGACTCCCACCATTCCGAGCTGGAAACGAGTATCTTATATTTCAGAAGATCATTAAGTTGGAATATGAC  900
 271  I  I  Y  Q  L  V  A  G  L  P  P  F  R  A  G  N  E  Y  L  I  F  Q  K  I  I  K  L  E  Y  D  300
 901 TTTCCAGAAAAATTCTTCCCTAAGGCAAGAGACCTCGTGGAGAAACTTTTGGTTTTAGATGCCACAAAGCGGTTAGGCTGTGAGGAAATG  990
 301  F  P  E  K  F  F  P  K  A  R  D  L  V  E  K  L  L  V  L  D  A  T  K  R  L  G  C  E  E  M  330
 991 GAAGGATACGGACCTCTTAAAGCACACCCGTTCTTCGAGTCCGTCACGTGGGAGAACCTGCACCAGCAGACGCCTCCGAAGCTCACCGCT 1080
 331  E  G  Y  G  P  L  K  A  H  P  F  F  E  S  V  T  W  E  N  L  H  Q  Q  T  P  P  K  L  T  A  360
1081 TACCTGCCGGCTATGTCGGAAGACGACGAGGACTGCTATGGCAATTATGACAATCTCCTGAGCCAGTTTGGCTGCATGCAGGTGTCTTCG 1170
 361  Y  L  P  A  M  S  E  D  D  E  D  C  Y  G  N  Y  D  N  L  L  S  Q  F  G  C  M  Q  V  S  S  390
1171 TCCTCCTCCTCACACTCCCTGTCAGCCTCCGACACGGGCCTGCCCCAGAGGTCAGGCAGCAACATAGAGCAGTACATTCACGATCTGGAC 1260
 391  S  S  S  S  H  S  L  S  A  S  D  T  G  L  P  Q  R  S  G  S  N  I  E  Q  Y  I  H  D  L  D  420
1261 TCGAACTCCTTTGAACTGGACTTACAGTTTTCCGAAGATGAGAAGAGGTTGTTGTTGGAGAAGCAGGCTGGCGGAAACCCTTGGCACCAG 1350
 421  S  N  S  F  E  L  D  L  Q  F  S  E  D  E  K  R  L  L  L  E  K  Q  A  G  G  N  P  W  H  Q  450
1351 TTTGTAGAAAATAATTTAATACTAAAGATGGGCCCAGTGGATAAGCGGAAGGGTTTATTTGCAAGACGACGACAGCTGTTGCTCACAGAA 1440
 451  F  V  E  N  N  L  I  L  K  M  G  P  V  D  K  R  K  G  L  F  A  R  R  R  Q  L  L  L  T  E  480
1441 GGACCACATTTATATTATGTGGATCCTGTCAACAAAGTTCTGAAAGGTGAAATTCCTTGGTCACAAGAACTTCGACCAGAGGCCAAGAAT 1530
 481  G  P  H  L  Y  Y  V  D  P  V  N  K  V  L  K  G  E  I  P  W  S  Q  E  L  R  P  E  A  K  N  510
1531 TTTAAAACTTTCTTTGTCCACACGCCTAACAGGACGTATTATCTGATGGACCCCAGCGGGAACGCACACAAGTGGTGCAGGAAGATCCAG 1620
 511  F  K  T  F  F  V  H  T  P  N  R  T  Y  Y  L  M  D  P  S  G  N  A  H  K  W  C  R  K  I  Q  540
1621 GAGGTTTGGAGGCAGCGATACCAGAGCCACCCGGACGCCGCTGTGCAGTGACGTGGCCTGCGGCCGGGCTGCCCTTCGCTGCCAGGACAC 1710
 541  E  V  W  R  Q  R  Y  Q  S  H  P  D  A  A  V  Q  *  556
1711 CTGCCCCAGCGCGGCTTGGCCGCCATCCGGGACGCTTCCAGACCACCTGCCAGCCATCACAAGGGGAACGCAGAGGCGGAAACCTTGCAG 1800
1801 CATTTTTATTT 1811
Nucleotide and deduced amino acid sequence of human PDK1. The
amino acid sequences that are underlined correspond to the
sequences of tryptic peptides isolated from PDK1 purified from rabbit
skeletal muscle. The kinase catalytic domain lies between residues 84
and 341 and the putative PH domain lies between residues 459 and
550. The asterisk denotes the stop codon in the DNA sequence. The
GenBank accession number for PDK1 is AF017995.
PKBα (35% identity). Although the PDK1 catalytic domain
possessed similarity to many protein kinases of the PKA
subfamily, only one of these showed homology to PDK1 in
the noncatalytic region: the Drosophila serine/threonine
protein kinase-61 (DSTPK61; GenBank accession number
Y07908; C.M., M. Todman and M.B., unpublished observa-
tions), which was not only 54% identical to PDK1 in the
catalytic domain, but was also very similar in the noncat-
alytic carboxy-terminal domain (Figure 2). This homology
was most striking between residues 450 and 550 of PDK1,
where the identity to DSTPK61 was 61% (79% similarity).
These observations suggested that DSTPK61 might be a
Drosophila homologue of PDK1. DSTPK61 contains a 60-
residue carboxy-terminal extension not found in PDK1 and
there is little homology between the amino-terminal 70
residues of PDK1 and the amino-terminal 150 residues of
DSTPK61 (Figure 2). PDK1 also lacks the polyglutamine
insertion near the amino terminus of DSTPK61 (residues
120–150) and a further polyacidic insertion located between
subdomains VII and VIII (residues 312–370) of the kinase
domain (Figure 2). The physiological role of DSTPK61 is
considered further in the Discussion section.
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Figure 2
Alignment of the amino acid sequences of human PDK1 and
Drosophila DSTPK61. The alignment was carried out using the Clustal
W program [46]. The catalytic domain is shown by a solid blue line
and comprises residues 84–341 of PDK1 and residues 164–486 of
DSTPK61. The putative PH domain is shown by a solid green line and
lies between residues 459 and 550 of PDK1 and 592 and 684 of
DSTPK61. Identical amino acids are shown in red.
Figure 3
Evidence that PDK1 and DSTPK61 possess a PH domain: sequence
alignment of PH domains that have a known tertiary structure with the
putative PH domains of PDK1 and DSTPK61. Alignment was done
using the program AMPS [47] and formatted using AMAS [48] with
some manual adjustment to ensure coincidence of secondary structure
regions. Regions containing conserved residues are coloured green
and the invariant tryptophan (Trp535) is coloured red. General regions
of secondary structure are denoted by the blue (β-strand) and green
(α-helix) bands. The PH sequences are those found in human
pleckstrin (PLS), human spectrin (SPC), human dynamin (DYN), and
rat phospholipase C-δ (PLCδ). Numbering is based on the PDK1
sequence (see Figure 1).
PDK1 and DSTPK61 possess a carboxy-terminal pleckstrin
homology domain
The high level of sequence conservation between PDK1
and DSTPK61, from residues 450–550 of PDK1 (Figure 2),
suggested that this region is likely to have an important
function. Inspection of these sequences indicated that they
are likely to be PH domains. These domains of ~100
residues, which have been found in over 70 other proteins,
are predicted to fold into similar three-dimensional struc-
tures and may mediate protein–lipid interactions,
protein–protein interactions, or both [24,25]. We have per-
formed sequence alignments of residues 459–550 in PDK1
and DSTPK61 with the PH domains of pleckstrin, spectrin,
dynamin and phospholipase C-δ, whose tertiary structures
have been determined (Figure 3), and with 71 other PH
domain sequences (data not shown). Although the sequence
identities between PH domains in general are poor [24,25],
there are certain residues that show a high level of conserva-
tion. For PDK1 and DSTPK61, a single position, namely
Trp535 of PDK1 (Figure 3), is invariant throughout the PH
domain family. Many similar amino acids are found at
defined regions of the PH domain (Figure 3) [24,25]. Sec-
ondary structure predictions also indicate that residues
459–525 of PDK1 are likely to contain regions of β-sheet,
while residues 528–542 (Figure 3) are likely to form an
extended α-helix, a prediction that is consistent with the
known structures of other PH domains [24,25].
Expression of GST–PDK1 and GST–DSTPK61
Residues 52–556 of PDK1 were expressed in human
embryonic kidney 293 cells and residues 1–752 of
DSTPK61 in Escherichia coli as fusion proteins with GST
at the amino terminus (hereafter termed GST–PDK1 and
GST–DSTPK61), and both were purified on glutathione-
Sepharose. The GST–PDK1 preparation showed two
bands with apparent molecular masses of 87 kDa and
85 kDa (Figure 4, Lane 1) and 2 mg of purified
GST–PDK1 protein were obtained from 20 (10 cm diame-
ter) dishes of cells. The GST–DSTPK61 preparation
showed a diffuse band at the expected molecular mass
(105 kDa) together with a number of minor degradation
products (Figure 4, Lane 2): 0.35 mg of GST–DSTPK61
were obtained from 0.5 l of bacterial culture.
GST–PDK1 and GST–DSTPK61 activate and phosphorylate
PKBa in a PtdIns(3,4,5)P3- or PtdIns(3,4)P2-dependent
manner
GST–PDK1 and GST–DSTPK61 both activated and phos-
phorylated GST–PKBα in the presence of a vesicle back-
ground containing phosphatidylcholine (PtdCho) and
phosphatidylserine (PtdSer), provided that PtdIns(3,4,5)P3
or PtdIns(3,4)P2 were included. The extent of activation of
GST–PKBα correlated with the extent of phosphorylation
(Figure 5), and no activation or phosphorylation occurred if
PtdIns(3,4,5)P3 or PtdIns(3,4)P2 were replaced by either
PtdIns(4,5)P2 or PtdIns3-P (Figure 5). Identical results
were obtained using purified PDK1 from rabbit skeletal
muscle and full-length GST–PDK1 (residues 1–556)
expressed in 293 cells (data not shown). A catalytically inac-
tive GST–PDK1 mutant in which Asp223 was changed to
alanine did not phosphorylate or activate GST–PKBα in
the presence of PtdCho/PtdSer lipid vesicles containing
PtdIns(3,4,5)P3 (data not shown). The specific activities of
GST–PDK1 (residues 52–556, 78,000 U/mg) and
GST–PDK1 (residues 1–556, 89,000 U/mg) towards
GST–PKBα in the presence of PtdIns(3,4,5)P3 were similar
to PDK1 purified from rabbit skeletal muscle
(100,000 U/mg), being over 200 times higher than that of
bacterially expressed GST–DSTPK61 (280 U/mg). Further
work is needed to establish whether this difference is
caused by misfolding of DSTPK61 or lack of an important
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Figure 4
SDS–polyacrylamide gel of purified GST–PDK1 and GST–DSTPK61.
GST–PDK1 residues 52–556 (lane 1; 3 µg protein) and
GST–DSTPK61 (lane 2; 6 µg protein) were electrophoresed on a
7.5% SDS–polyacrylamide gel and stained with Coomassie blue. The
position of the molecular mass markers glycogen phosphorylase
(97 kDa), bovine serum albumin (66 kDa) and ovalbumin (43 kDa) are
indicated. The other GST–PDK1 constructs used in this study were all
expressed at a similar level of purity as the GST–PDK1 preparation
shown in lane 1 (data not shown).
kDa
97
66
43
1 2
GST–DSTPK61
GST–PDK1
post-translational modification when it is expressed in E.
coli, or whether DSTPK61 does not recognise human PKBα
as well as human PDK1. Some activation and phosphoryla-
tion of GST–PKBα was obtained using very high concen-
trations of GST–PDK1 or GST–DSTPK61 in the absence
of PtdIns(3,4,5)P3 or PtdIns(3,4)P2. However, the activity of
PDK1 was enhanced about 1000-fold in the presence of
these inositol phospholipids. In the presence of
PtdIns(3,4,5)P3 and at high concentrations of GST–PDK1
and GST–DSTPK61, the phosphorylation of GST–PKBα
reached 0.75 moles of phosphate per mole of protein and
was paralleled by a 35-fold increase in activity. This was
similar to the maximal activation of GST–PKBα obtained
using PDK1 from skeletal muscle [21]. 
Expressed PDK1 and DSTPK61 phosphorylate PKBa at
Thr308
32P-labelled GST–PKBα that had been maximally phos-
phorylated with either GST–PDK1 (Figure 6a) or
GST–DSTPK61 (Figure 6b) was digested with trypsin and
chromatographed on a C18 column. One major 32P-labelled
peptide was obtained in each case. This peptide eluted at
26% acetonitrile at the same position as the 32P-labelled
PKBα tryptic phosphopeptide comprising residues
308–327 [20,21]. This peptide contained phosphothreo-
nine, and when subjected to solid phase sequencing, 32P-
radioactivity was released after the first cycle of Edman
degradation, confirming Thr308 as the site of phosphory-
lation (data not shown). 
PKBa is activated by cotransfection with PDK1 in 293 cells
and phosphorylated at Thr308
In order to determine whether PDK1 was capable of acti-
vating PKBα in a cellular context, we transfected a haemag-
glutinin epitope-tagged PKBα (HA–PKBα) into 293 cells,
either alone or together with Myc epitope-tagged PDK1
(Myc–PDK1). As reported previously, HA–PKBα pos-
sessed a low basal activity when transfected alone into 293
cells, which was increased 40-fold after stimulation with
IGF1 (Figure 7) [20]. When 293 cells were transfected with
both HA–PKBα and Myc–PDK1, however, the activity of
HA–PKBα was increased 20-fold in unstimulated cells and
70-fold after stimulation with IGF1 (Figure 7). When 293
cells were transfected with HA–PKBα and a catalytically
inactive mutant of PDK1 (Myc–D223A-PDK1), HA–PKBα
was not activated significantly (Figure 7).
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Figure 5
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GST–PDK1 and GST–DSTPK61 activate and phosphorylate PKBα in a
PtdIns(3,4,5)P3- or PtdIns(3,4)P2-dependent manner. GST–PKBα was
incubated for 30 min at 30°C with 1 unit/ml (a,b) GST–PDK1 (residues
52–556) or (c,d) GST–DSTPK61 with Mg[γ32P]ATP and phospholipid
vesicles containing 100 µM PtdCho, 100 µM PtdSer, and various PtdIns
lipids (numbered 1–5, see below) all at a final concentration of 10µM in
the assay. Under these conditions, the increase in PKBα activity and
phosphorylation was linear with respect to time (see Materials and
methods). In (a) and (c), the assays were terminated by making the
incubations 1% (by volume) in Triton X-100 (see [21]), and the increase
in specific activity of GST–PKBα was determined. In (b) and (d), the
reactions were terminated by making the solutions 1% in SDS, the
samples were subjected to SDS–polyacrylamide gel electrophoresis,
and the phosphorylation was assessed by autoradiography of the
Coomassie blue stained band corresponding to GST–PKBα. The
results are presented in (a) and (c) as the increase in the specific activity
of GST–PKBα (U/mg), relative to a control incubation in which
GST–PDK1 or GST–DSTPK61 was omitted (± SEM for 6–9
determinations, three independent experiments). The basal activity of
GST–PKBα was 2.5 U/mg. Lane 1, buffer control; lane 2, sn-1-stearoyl,
2-arachidonyl D-PtdIns(3,4,5)P3; lane 3, sn-1,2-dipalmitoyl D-
PtdIns(3,4)P2; lane 4, PtdIns(4,5)P2 (purified from Folch brain fraction);
lane 5, sn-1,2-dipalmitoyl D-PtdIns-3P.
In order to establish the mechanism by which overexpres-
sion of PDK1 in 293 cells induced the activation of PKBα,
the cells were incubated with 32P-phosphate, stimulated
with buffer or IGF1 and 32P-labelled HA-PKBα was
immunoprecipitated from the lysates. After digestion with
trypsin, the resulting peptides were analysed by C18 chro-
matography (Figure 8). As observed previously [20],
HA–PKBα is phosphorylated at Ser124 and Thr450 in
unstimulated cells, and IGF1 stimulation induces the
phosphorylation of Thr308 and Ser473 (Figure 8). In con-
trast, when cotransfected with PDK1, HA–PKBα became
partially phosphorylated at Thr308 in unstimulated 293
cells, to a level that was 70% of that observed in IGF1-
stimulated cells transfected with HA–PKBα alone. This
phosphorylation of Thr308 was increased a further four-
fold in response to IGF1 (Figure 8). Importantly, cotrans-
fection of Myc–PDK1 with HA–PKBα did not induce
phosphorylation of HA–PKBα at Ser473 in unstimulated
cells, nor did it potentiate the level of Ser473 phosphoryla-
tion following IGF1 stimulation (Figure 8). 
Role of the PH domain in the activation of PKBa by PDK1
A GST–PKBα mutant lacking the PH domain (GST–∆PH-
PKBα, residues 118–479) possessed a threefold higher basal
activity than that of full-length wild-type GST–PKBα and
was activated (Figure 9a) and phosphorylated (data not
shown) by PDK1 in a PtdIns(3,4,5)P3-independent manner.
The rate of activation, however, was reduced about 20-fold
compared to wild-type GST–PKBα (Figure 9a). PDK1
purified from rabbit skeletal muscle extracts also activated
and phosphorylated GST–∆PH-PKBα in a PtdIns(3,4,5)P3-
independent manner (data not shown).
A PDK1 mutant lacking the putative carboxy-terminal PH
domain was expressed as a GST fusion protein in 293 cells
(GST–∆PH-PDK1, residues 1–450). We found that this
form of PDK1 was still able to activate GST–PKBα in a
PtdIns(3,4,5)P3-dependent manner, but the rate of activa-
tion was reduced about 30-fold compared to full-length
wild-type GST–PDK1 (Figure 9b). As observed with
PDK1 purified from rabbit skeletal muscle [21] or full-
length GST–PDK1 (data not shown), GST–∆PH-PDK1
was activated more effectively by the D-enantiomer of sn-
1-stearoyl, 2-arachidonyl PtdIns(3,4,5)P3 than by the D-
enantiomer of sn-1,2-dipalmitoyl D-PtdIns(3,4,5)P3, and no
activation was induced by the L-enantiomer of sn-1-
stearoyl, 2-arachidonyl PtdIns(3,4,5)P3 (Figure 9b). In
contrast, sn-1,2-dipalmitoyl D-PtdIns(3,4)P2 was very poor
at inducing the activation of GST–PKBα by GST–∆PH-
PDK1 (Figure 9b) under conditions where this lipid was
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Figure 6
PDK1 phosphorylates PKBα at Thr308.
GST–PKBα was maximally phosphorylated by
incubation for 30 min with 25 U/ml of either
(a) GST–PDK1 (residues 52–556) or (b)
GST–DSTPK61 and phospholipid vesicles
comprising PtdCho, PtdSer, the D-enantiomer
of 1-stearoyl, 2-arachidonyl PtdIns(3,4,5)P3
and Mg–γ[32P]-ATP (106 cpm/nmol). After
30 min, the samples were alkylated with 
4-vinylpyridine, digested with trypsin [21] and
applied to a Vydac 218TP54 C18 column
equilibrated in 0.1% (v/v) trifluoroacetic acid.
The column was developed with a linear
acetonitrile gradient (diagonal line) at a flow
rate of 0.8 ml/min and fractions of 0.4 ml were
collected. 38% (a) and 45% (b) of the
radioactivity applied to the column was
recovered in the major 32P-containing peptide
eluting at 26% acetonitrile, which contains
Thr308. The elution position of the tryptic
peptide containing Ser473 is also marked
(see [20] and Figure 8).
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as effective as sn-1,2-dipalmitoyl D-PtdIns(3,4,5)P3 at
stimulating GST–PKBα activation by either full-length
GST–PDK1 (data not shown) or PDK1 purified from
rabbit skeletal muscle [21].
PDK1 is not activated or phosphorylated by IGF1
293 cells were serum starved for 16 hours, stimulated with
IGF1, lysed and the endogenous PDK1 activity present in
the cell lysates was determined after chromatography on
heparin–Sepharose (see Materials and methods). IGF1
stimulation of cells for up to 10 minutes did not result in any
activation or inhibition of PDK1 activity (data not shown). 
In order to see whether IGF1 stimulation was inducing
the phosphorylation of PDK1, 293 cells were transfected
with Myc–PDK1 (residues 52–556), incubated with 
32P-phosphate, stimulated with buffer or IGF1 for
5 minutes and 32P-labelled Myc–PDK1 was immunopre-
cipitated from the lysates. After digestion with trypsin, the
resulting peptides were analysed by C18 chromatography.
These experiments demonstrate that PDK1 is phosphory-
lated at four tryptic peptides (only on serine residues) in
unstimulated cells and that IGF1 does not alter the phos-
phorylation of any of these peptides (data not shown).
Treatment of PDK1 purified from rabbit skeletal muscle
with high concentrations of the serine/threonine-specific
protein phosphatase 2A and protein tyrosine phosphatase
1B also had no effect on activity (data not shown). One of
the in vivo phosphorylation sites on PDK1 was identified
as Ser241, which lies in the equivalent position to the
Thr308 of PKB in the kinase domain. 
Discussion
PDK1 purified 500,000-fold from skeletal muscle [21]
contains three proteins with apparent molecular masses of
85 kDa, 45 kDa and 67–69 kDa and, in this paper, we
have established that the 67–69 kDa component is PDK1.
When cloned and expressed in 293 cells, this protein acti-
vated PKBα and induced its phosphorylation at Thr308,
both activation and phosphorylation being dependent on
PtdIns(3,4,5)P3 or PtdIns(3,4)P2. When overexpressed in
293 cells, PDK1 also activated PKBα in cotransfection
experiments and potentiated the phosphorylation of
Thr308 by IGF1. These observations and the finding that,
like PKB, the mRNA encoding PDK1 is expressed ubiq-
uitously (Table 1) are consistent with PDK1 lying
‘upstream’ of PKBα in vivo. 
It is of interest that PDK1 lies in the same subfamily of
protein kinases as PKB. Moreover, like PKB, it also con-
tains a PH domain although, in contrast to PKB, this is
located carboxy-terminal to the catalytic domain [13]. The
PH domain in PKBα is capable of binding PtdIns(3,4,5)P3
and PtdIns(3,4)P2 at micromolar concentrations [26,27],
which may facilitate its translocation to the plasma mem-
brane, which occurs in response to IGF1 in 293 cells
(M. Andjelkovic et al., unpublished observations) or inter-
leukin-2 stimulation of EL4⋅IL-2 cells [28] to form a sig-
nalling complex ([21]; M. Andjelkovic et al., unpublished
observations). However, the finding presented in this
paper that PDK1 is not activated by IGF1, and that a
mutant of PKBα lacking the PH domain is activated and
phosphorylated independently of PtdIns(3,4,5)P3
(Figure 9a), demonstrates that the PtdIns(3,4,5)P3-induced
activation of PKBα by PDK1 is substrate directed, at least
in part. It is possible that the binding of PtdIns(3,4,5)P3 to
the PH domain of PKBα alters the conformation of PKBα
so that Thr308 becomes accessible for phosphorylation by
PDK1. Consistent with this model, deletion of the PH
domain of PDK1 resulted in an enzyme that is still able to
activate and phosphorylate PKBα in a PtdIns(3,4,5)P3-
dependent manner (Figure 9b).
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Figure 7
PKBα is activated by cotransfection with PDK1 in 293 cells. (a) 293
cells were transiently transfected with DNA constructs expressing
either HA–PKBα or both HA–PKBα and Myc–PDK1 (residues
52–556) or a catalytically inactive Myc–PDK1 (Myc–D223A-PDK1,
residues 1–556). The cells were then stimulated for 10 min with or
without 100 ng/ml IGF1, the HA–PKBα immunoprecipitated from the
lysates and assayed. The results are expressed relative to the specific
activity of wild-type HA–PKBα in unstimulated 293 cells
(0.5 ± 0.03 U/mg). No PKBα activity was detected in mock
transfections in which the cells were transfected with PCMV5 vector
alone (data not shown). (b) Protein (6 µg) from each lysate was
electrophoresed on a 10% SDS–polyacrylamide gel and
immunoblotted using either a monoclonal HA antibody or Myc antibody
to detect HA–PKBα or Myc–PDK1, respectively. 
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The rate of activation of PKBα by PDK1 is, however,
reduced 30-fold when the PH domain of PDK1 is deleted.
Thus, it remains possible that the PH domain of PDK1
binds PtdIns(3,4,5)P3 and that this greatly enhances the
rate of activation of PKBα. PtdIns(3,4,5)P3 can stimulate
the activation of PKBα by PDK1 only when it is pre-
sented in lipid vesicles containing PtdCho and PtdSer
[21], and a PDK1 mutant lacking the PH domain may not
be able to interact with lipids and hence be unable to pen-
etrate these vesicles efficiently. This may account for the
greatly reduced rate at which PDK1 lacking the PH
domain activates PKBα. PKBα lacking the PH domain is
also presumably unable to penetrate lipid vesicles and this
may explain why this mutant is phosphorylated at a 20-
fold lower rate by GST–PDK1 than full-length PKBα
(Figure 9a). It is clearly critical to study the interaction of
PDK1 with 3-phosphoinositides.
Recently, an enzyme with very similar properties to PDK1
has been partially purified from COS-1 and brain cell
cytosol extracts [29]. Like PDK1, this kinase phosphory-
lated Thr308 of PKBα only in the presence of
PtdIns(3,4,5)P3 and PtdIns(3,4)P2 and not PtdIns(4,5)P2
lipids. Furthermore, this activity was found not to phos-
phorylate PKBα mutants that could not interact with
PtdIns(3,4,5)P3. This finding is consistent with the idea
that interaction of PtdIns(3,4,5)P3 with the PH domain of
PKBα is required to permit phosphorylation of Thr308 of
PKBα by upstream kinases. In contrast to our work with
purified PDK1, the kinase from brain cytosol phosphoryla-
tion of ∆PH-PKBα was still activated three-fold by the
addition of PtdIns(3,4,5)P3, whereas PDK1 phosphoryla-
tion of ∆PH-PKBα is not significantly activated by
PtdIns(3,4,5)P3 (Figure 9). It will be important to establish
whether the activity described in [29] is actually PDK1 or
another enzyme capable of activating PKBα by phospho-
rylating Thr308.
Although PKBα is activated by cotransfection with PDK1
in 293 cells, and phosphorylation of PKBα at Thr308
induced by IGF1 is potentiated, the overexpression of
PDK1 does not potentiate the activation of PKBα by
IGF1 (Figure 7). The reason is that the activation of
PKBα also requires phosphorylation of Ser473, and phos-
phorylation of Thr308 and Ser473 have synergistic effects
on activity [20]. An important finding made in the present
study is that PKBα does not become phosphorylated at
Ser473 when cotransfected with PDK1, and nor does
transfection with PDK1 affect the level of Ser473 phos-
phorylation attained after stimulation with IGF1. These
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Figure 8
Overexpression of PDK1 induces
phosphorylation of PKBα at Thr308. 293 cells
transiently transfected with either (a,c) wild-
type HA–PKBα or (b,d) HA–PKBα and
Myc–PDK1 (residues 52–556) were
incubated with 32P-orthophosphate, then
treated for 10 min without (a,b) or with (c,d)
100 ng/ml IGF1. The 32P-labelled HA–PKBα
was immunoprecipitated from the lysates,
treated with 4-vinylpyridine and
electrophoresed on a 10% polyacrylamide gel.
The HA–PKBα was excised from the gel,
digested with trypsin and chromatographed on
a C18 column (see Figure 6 legend) to resolve
the four major phosphopeptides that are
phosphorylated at Ser124, Ser473, Thr308
and Thr450, respectively [20]. The identity of
each phosphopeptide was established by
phospho-amino acid analysis and solid phase
sequencing. Similar results were obtained in
two separate experiments for (a,c) and in three
separate experiments for (b,d).
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experiments demonstrate that the protein kinase that
phosphorylates PKBα at Ser473 is not activated by PDK1,
and that phosphorylation of PKBα at Thr308 in a cellular
context does not cause PKBα to autophosphorylate at
Ser473. Like the phosphorylation of Thr308, Ser473 phos-
phorylation is prevented by incubating cells with wort-
mannin prior to stimulation with insulin or IGF1. It will
be interesting to know whether the Ser473 kinase is acti-
vated directly by PtdIns(3,4,5)P3 or whether the binding
of PtdIns(3,4,5)P3 to PKBα alters its conformation to
permit phosphorylation by the Ser473 kinase. 
PDK1 was found to be homologous to DSTPK61, a
Drosophila protein kinase that has been implicated in the
regulation of sex differentiation, oogenesis and spermato-
genesis (C.M., M. Todman and M.B., unpublished obser-
vations). The identity between PDK1 and DSTPK61 was
54% in the catalytic domain, but even greater (61% iden-
tity) in the putative PH domain (Figure 2), further suggest-
ing an important functional role for the PH domain of
PDK1. DSTPK61 expressed in E. coli activated human
PKBα and phosphorylated it specifically at Thr308 in a
PtdIns(3,4,5)P3- or PtdIns(3,4)P2-dependent manner
(Figure 5). These findings indicate that DSTPK61 is a
Drosophila homologue of PDK1 and suggest that one of its
roles may be to activate the Drosophila PKB (termed
DPKB), which was identified several years ago [30,31].
Although the physiological roles of DSTPK61 in
Drosophila are unknown, the findings presented in this
paper suggest that DPKB may lie downstream of
DSTPK61 in signalling pathways regulating sex differenti-
ation and oogenesis (C.M., M. Todman and M.B., unpub-
lished observations). Since PtdIns 3-kinases play a major
role in the activation of PKB in mammalian cells [4–6,13],
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Role of the PH domains of PKBα and PDK1. (a) 0.5 µg of either
GST–PKBα or GST–∆PH-PKBα were incubated for 30 min at 30°C
with 2.3 nM GST–PDK1 (residues 1–556) with Mg[γ32P]ATP and
phospholipid vesicles containing 100 µM PtdCho, 100 µM PtdSer
either in the presence or absence of 10 µM PtdIns(3,4,5)P3 in a 20 ml
assay. The assays were terminated by making the incubations 1% (by
volume) in Triton X-100 [21], and the increase in specific activity of
GST–PKBα was determined. The basal activity of GST–PKBα was
2.5 U/mg and that of GST–∆PH-PKBα was 8 U/mg. At the high
concentration of GST–PDK1 used in this assay, the rate of activation
of full-length wild-type GST–PKBα is not linear with time, whereas the
activation of GST–∆PH-PKBα is linear. When the experiments are
carried out at 20-fold lower concentrations of GST–PDK1, a similar
extent of activation of wild-type GST–PKBα is achieved as that shown
in the figure for GST–∆PH-PKBα by 2.3 nM GST–PDK1. (b) As in (a)
except that 0.5 µg of GST–PKBα were incubated with 2.5 nM
GST–∆PH-PDK1 (residues 1–450) in the presence of phospholipid
vesicles containing 100 µM PtdCho, 100 µM PtdSer and 10 µM of
either sn-1-stearoyl, 2-arachidonyl D-PtdIns(3,4,5)P3 (lane 1); sn-1-
stearoyl, 2-arachidonyl L-PtdIns(3,4,5)P3 (lane 2), sn-1,2-dipalmitoyl D-
PtdIns(3,4,5)P3 (lane 3), sn-1,2-dipalmitoyl D-PtdIns(3,4)P3 (lane 4),
PtdIns(4,5)P2 (purified from Folch brain fraction; lane 5) or sn-1,2-
dipalmitoyl D-PtdIns-3P (lane 6). The results are presented as the
increase in the specific activity of GST–PKBα (U/mg; ± SEM for 6–9
determinations, three independent experiments), relative to a control
incubation in which GST–PDK1 is omitted.
it is likely that a Drosophila PtdIns 3-kinase also plays an
important role in the activation of DSTPK61 and DPKB.
Little is known about the role of PtdIns 3-kinase in
Drosophila [32]. However, a Drosophila PtdIns 3-kinase cat-
alytic subunit termed Dp110 has been overexpressed in
the wing and eye imaginal discs of Drosophila, in a normal,
a constitutively active and a dominant-negative form [33].
The results of these studies showed that PtdIns 3-kinase is
likely to play a role in regulating cell growth [34]. Interest-
ingly, loss-of-function mutations in the Drosophila insulin
receptor (Inr) also inhibited cell growth in imaginal discs
and resulted in flies that were much smaller than wild type
[34]. Taken together these results suggest that Drosophila
PtdIns 3-kinases might be important targets of the insulin
receptor [32] and, perhaps by acting through DSTPK61
and DPKB, may regulate cell growth.
The DSTPK61 gene is differentially spliced in male and
female Drosophila (C.M., M. Todman and M.B., unpub-
lished observations). This generates many different tran-
scripts that all have the same open reading frame and,
therefore, produce the same protein, but differ significantly
in their 5′ and 3′ untranslated regions. This is likely to
result in different levels of expression of the DSTPK61
protein in male and female Drosophila (C.M., M. Todman
and M.B., unpublished observations). In view of the role of
PKB in regulating apoptosis in mammalian cells (see Back-
ground), it is possible that the function of DSTPK61 during
oogenesis, spermatogenesis and in female adults in relation
to sex determination might be related to cell survival or cell
death decisions. One could imagine the low level of the
non-sex-specific transcript of DSTPK61 being responsible
for a general growth function consistent with the role of
overexpression of Dp110 in cells [33] and the specifically
spliced forms seen in female carcasses and ovaries and male
testes being controlled translationally, leading to the gener-
ation of high levels of protein at specific times. 
It should be remembered that the extent and duration of
activation of the MAP kinase cascade is critical in determin-
ing whether a signal induces the proliferation of PC12 cells
or their differentiation to a sympathetic neurone like phe-
notype [35,36]. Similarly, different levels of expression of
DSTPK61 are likely to affect the extent and duration of
activation of PKB in vivo and hence may determine the
precise function of this kinase cascade. There are two sig-
nalling pathways involved in sex differentiation in which
such a situation may operate. The first involves the devel-
opment of a specific adult male muscle in the abdomen
required for holding the female fly during mating [37]. This
muscle develops in males only in response to an unknown
signal generated by adjacent nerve cells. It is likely that a
signalling pathway causes muscle cells in that region of the
female fly to apoptose, whereas in male flies the growth of
these muscle cells is promoted [37]. The second pathway
involves an unknown signalling mechanism that operates
between the somatic cells and germ cells in the male and
female gonads, in which a signal derived from the somatic
cells initiates a signalling pathway that promotes survival of
germline cells and induces these to differentiate into sperm
and oocytes [38,39]. The mediators of both of these sig-
nalling pathways are at present unknown but, in light of the
findings presented in this paper, it is possible that the
unknown signals induce the sequential activation of PtdIns
3-kinase, DSTPK61 and DPKB. The role of this pathway
could then be to mediate cell survival by inhibiting apopto-
sis. To understand the function of these signalling path-
ways, future work will have to concentrate on obtaining
mutants of the Drosophila DSTPK61, PKB and PtdIns 3-
kinase genes, as well as identifying the specific signals that
switch on these pathways. It would be of considerable inter-
est to compare the effects of expressing constitutively
active and dominant-negative forms of Inr, Dp110,
DSTPK61 and DPKB during oogenesis, spermatogenesis
and sex-specific muscle differentiation.
Materials and methods
Materials
All phospholipids were obtained from the sources described previously
[21]. Glutathione-Sepharose, the pGEX-3X expression vector and 1 ml
heparin-Sepharose columns (HiTrap) were purchased from Pharmacia
(Milton Keynes, UK), monoclonal 12CA5 and 9E10 antibodies from
Boehringer Mannheim (Lewes, UK), alkylated trypsin and the pSP72
cloning vector from Promega (Southampton, UK), and the pCR 2.1-
TOPO cloning vector from Invitrogen (Leek, Netherlands). GST–PKBα
and sources of all other materials are described in [21]. The GenBank
accession number for PDK1 is AF017995.
Buffer solutions
Buffer A contained 50 mM Tris/HCl pH 7.5, 1 mM EDTA, 1 mM EGTA,
1% (by volume) Triton X-100, 1 mM sodium orthovanadate, 10 mM
sodium β-glycerophosphate, 50 mM NaF, 5 mM sodium pyrophos-
phate, 1 µM microcystin-LR, 0.27 M sucrose, 1 µM benzamidine,
0.2 µM phenylmethylsulphonyl fluoride (PMSF), 10 µg/ml leupeptin and
0.1% (by volume) 2-mercaptoethanol. Buffer B contained 50 mM
Tris/HCl pH 7.5, 0.1 mM EGTA, 0.03% (by volume) Brij-35, 0.27 M
sucrose and 0.1% (by volume) 2-mercaptoethanol. Buffer C contained
50 mM sodium phosphate pH 7.5 and 0.15 M NaCl.
Tryptic digestion of PDK1 and amino acid sequencing
PDK1 purified from 500 g of skeletal muscle [21] was denatured in 1%
(by mass) SDS, electrophoresed on a 7.5% SDS–polyacrylamide gel
and stained with Coomassie blue. After destaining, gel pieces contain-
ing the 85 kDa, 45 kDa and 67–69 kDa bands (~0.5 µg protein per
band) were excised, digested with trypsin and the resulting peptides
chromatographed on a Vydac C18 column and sequenced [40]. 
Cloning of PDK1
Most of the open reading frame of PDK1 was derived by interrogation
of the dbEST database at the National Centre for Biological Information
(http://www.ncbi.nlm.nih.gov/dbEST/index.html). A full-length cDNA
clone for PDK1 was isolated by hybridisation screening of a cDNA
library, in the vector λZAP, made from the human breast cancer cell line
MCF7 (a gift of P. Mitchell, Institute of Cancer Research, Sutton, UK).
The PDK1 probe for the screening was generated by RT-PCR with the
primers CTGAGCCAGTTTGGCTGC and ACGTCCTGTTAGGCGT-
GTGG, corresponding to nucleotides 1138–1567 of the PDK1
sequence, with MCF7 cDNA as template. DNA sequencing was
carried out on an Applied Biosystems 373A DNA automatic sequencer
using the Taq dye terminator cycle sequencing kit. 
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Preparation of DNA expression constructs encoding PDK1
and GST–DSTPK61
Two overlapping human EST cDNA clones encoding PDK1 (GenBank
accession numbers AA121994 and AA186323), corresponding to
nucleotides 98–708 and 467–1811 of PDK1 (Figure 1), were
obtained from the I.M.A.G.E. consortium [41] and sequenced. The two
sequences were joined together by a ScaI restriction enzyme digest of
each EST clone, and the appropriate restriction fragments obtained
from these digests were ligated to generate a plasmid containing a
continuous PDK1 sequence from nucleotides 154–1670. This con-
struct was used as a template for a PCR reaction to generate an
amino-terminal epitope-tagged Myc–PDK1 (amino acid residues
52–556) construct. This was achieved using the 5′ primer
GCGGAGATCTGCCACCATGGAGCAGAAGCTGATCTCTGAAGA
GGACTTGGACGGCACTGCAGCCGAGCCTCGG and the 3′ primer
GCGGGGTACCTCACTGCACAGCGGCGTCCGGGTG, which
incorporate a BglII site (bold) and a KpnI site (bold italics). The result-
ing PCR fragment was subcloned into the BglII–KpnI sites of an
pSP72 cloning vector, and the nucleotide sequence confirmed by DNA
sequencing. The Myc–PDK1 coding sequence was subcloned from
this vector as a BglII–KpnI fragment into the BamHI and KpnI site of
the eukaryotic expression vector pEBG-2T [42] in order to generate a
construct for the expression of GST–PDK1 in 293 cells, while a
BglII–SalI fragment was ligated into pCMV5 [43] to generate a con-
struct for the expression of Myc–PDK1 in 293 cells.
Amino-terminal Myc epitope tagged PDK1 constructs encoding the
full-length protein (residues 1–556) and lacking the PH domain
(residues 1–450) were generated by a PCR approach using the full-
length PDK1 cDNA isolated from the MCF7 library. This was achieved
by using the the 5′ primer GCGGAGATCTGCCACCAT-
GGAGCAGAAGCTGATCTCTGAAGAGGACTTGGCCAGGACCAC
CAGCCAGCTGTATGACG (for both the full-length and ∆PH-PDK1
constructs) and the 3′ primers GCGGGGTACCTCACTGCACAGCG-
GCGTCCGGGTG (for full-length PDK1) and GCGGGGTAC-
CTCAGTGCCAAGGGTTTCCGCCAGCCTGCTT (for the ∆PH-PDK1
construct). The resulting PCR fragments were cloned into the pCR 2.1-
TOPO vector and subsequently subcloned into the pEGB-2T vector as
a BglII–KpnI fragment and pCMV5 as an EcoRI–KpnI fragment. A full-
length catalytically inactive PDK1 construct in which Asp223 was
changed to Ala was created by the PCR-based megaprimer strategy
[44] and then subcloned into pCMV5 and pEBG-2T as described
above. The structure of each construct was verified by DNA sequenc-
ing, and plasmid DNA for transfection was purified using the Qiagen
plasmid Mega kit according to the manufacturer’s protocol. 
A bacterial expression vector for GST–DSTPK61 was prepared by
ligating an EcoRI–EcoRV fragment of the Dstpk61 cDNA derived
from pBluescriptSK into the EcoRI–SalI site of the pGEX-3X expres-
sion vector.
Preparation of DNA expression constructs encoding
GST–∆PH-PKBα
A PCR-based strategy was used to prepare a GST–∆PH-PKBα
(encoding residues 118–479 of PKBα) construct, using as a template
a full-length human PKBα construct that was isolated from a human
skeletal muscle cDNA library and subcloned into the pBluescriptSK
vector (M. Deak and D. Alessi, unpublished data). The GST–∆PH-
PKBα construct was obtained using the 5′ primer CGGGATCCATG-
GACTTCCGGTCGGGCTCA and the 3′ primer was the T7
oligonucleotide of pBluescriptSK vector. The resulting PCR fragment
was cloned into pBluescriptSK as a BamH1–KpnI fragment and sub-
sequently into pEBG-2T as a BamH1–KpnI fragment. 
Expression of GST–PDK1, GST–∆PH-PDK1, GST–D223A-
PDK1, GST–∆PH-PKBα and GST–DSTPK61
Twenty 10 cm diameter dishes of human embryonic kidney 293 cells
were cultured and each dish transfected with 20 µg DNA encoding
GST–PDK1 (residues 52–556), GST–PDK1 (residues 1–556),
GST–∆PH-PDK1, GST–D223A-PDK1 or GST–∆PH-PKBα using a
modified calcium phosphate method [20]. 24 h after transfection, the
cells were serum starved for 16 h and each dish of cells lysed in 1 ml of
ice-cold Buffer A. The 20 lysates were pooled, centrifuged at 4°C for
10 min at 13,000 × g and the supernatant incubated for 60 min on a
rotating platform with 1 ml of glutathione-Sepharose previously equili-
brated in Buffer A. The suspension was centrifuged for 1 min at 3000 ×
g, the beads washed three times with 10 ml Buffer A containing 0.5 M
NaCl, and then a further 10 times with 10 ml of Buffer B to ensure
complete removal of all the Triton X-100, which interferes with the acti-
vation of GST–PKBα by PDK1 [21]. GST–PDK1α was eluted from the
resin at ambient temperature with three 1 ml portions of Buffer B con-
taining 20 mM glutathione pH 8.0 and 0.27 M sucrose. The combined
eluates were divided into aliquots, snap frozen in liquid nitrogen and
stored at –80°C. Between 0.5 and 2.0 mg of each GST fusion protein
were obtained and were more than 90% homogeneous as judged by
SDS–polyacrylamide gel electrophoresis.
E. coli transformed with an expression plasmid encoding
GST–DSTPK61 were grown at 37°C in LB medium to an absorbance of
0.6 at 600 nm. Isopropyl-β-D-thiopyranoside was added to 30 µM and
the bacteria were incubated for 16 h at 25°C before centrifuging for
10 min at 4000 × g. The bacteria were resuspended in 15 ml of Buffer A
and lysed by sonication for 4 min on ice. The suspension was centrifuged
for 30 min at 30,000 × g and the GST–DSTPK61 was purified by affinity
chromatography on 1 ml of glutathione-Sepharose as described above
for GST–PDK1. The GST–DSTPK61 derived from this (0.35 mg/ml) was
divided into aliquots, snap frozen in liquid nitrogen and stored at –80°C.
Assay of GST–PDK1 and GST–DSTPK61 activity
GST–PDK1 and GST–DSTPK61 were diluted appropriately in Buffer
B containing 1 mg/ml bovine serum albumin and assayed for their
ability to activate and phosphorylate GST–PKBα [21]. One unit of
PDK1 activity was defined as that amount required to increase the
basal activity of GST–PKBα by 1 unit of activity in 1 min; 1 unit of
GST–PKBα activity was that amount of enzyme required to catalyse
the phosphorylation of 1 nmol of the peptide RPRAATF in 1 min in an
assay containing 0.1 mM RPRAATF [45]. In order to ensure that the
assay was linear with respect to time, the concentration of GST–PDK1
or GST–DSTPK61 was kept below 2 units/ml. At this concentration,
the level of phosphorylation of PKBα was < 0.4 moles of phosphate per
mole of protein in the 30 min assay.
Transfection of 293 cells with HA-tagged PKBα and
Myc–PDK1
Human embryonic kidney 293 cells were cultured on 10 cm diameter
dishes and transfected with 1 mg/ml pCMV5 DNA constructs encod-
ing HA–PKBα or HA–PKBα plus Myc–PDK1 or HA–PKBα plus
Myc–D223A-PDK1 [20]. After 24 h the cells were deprived of serum
for a further 16 h and then stimulated for 10 min with either 100 ng/ml
IGF1 or Buffer C. The cells were lysed in 1.0 ml of ice-cold Buffer A,
the lysate centrifuged at 4°C for 10 min at 13,000 × g and HA–PKBα
immunoprecipitated from aliquots of the supernatant (10 mg protein)
[20] and assayed for PKBα activity with the peptide RPRAATF [45] as
described previously [20].
32P-labelling of 293 cells transfected with HA–PKBα or
Myc–PDK1
This was carried out essentially as described previously [20]. Briefly, 293
cells were transfected with HA–PKBα, or with HA–PKBα plus
Myc–PDK1, washed with phosphate-free Dulbecco's modified Eagle's
medium (DMEM), incubated for 4 h with 32P-orthophosphate (1 mCi/ml),
then stimulated with IGF1 (100 ng/ml) for 5 min. The cells were lysed
and the HA–PKBα immunoprecipitated (using 10 µg of 12CA5 antibody
per 10 cm dish of cells) or the Myc–PDK1 immunoprecipitated (using
10 µg of 9E10 antibody per 10 cm dish of cells). The immunoprecipi-
tated protein was alkylated with 4-vinylpyridine, subjected to SDS–poly-
acrylamide gel electrophoresis, digested with trypsin and analysed by
chromatography on a C18 column [20]. 
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Measurement of PDK1 activity in 293 cell extracts.
293 cells cultured on 10 cm diameter dishes (five dishes for each
determination of PDK1 activity) were deprived of serum for a further
16 h and then stimulated for 2 or 10 min with either 100 ng/ml IGF1 or
Buffer C. The cells were lysed in 1.0 ml of ice-cold Buffer A containing
0.2 M NaCl, the lysate centrifuged at 4°C for 10 min at 13,000 × g and
applied to a 1 ml heparin-Sepharose column (HiTrap) equilibrated in
Buffer B containing 0.2 M NaCl, and the column washed until the
absorbance at 280 nm had decreased back to the baseline. The
column was developed with a 40 ml linear salt gradient to 2.0 M NaCl
and 1.0 ml fractions were collected. The column fractions were
assayed for PDK1 activity in the presence and absence of
PtdCho/PtdSer lipid vesicles containing PtdIns(3,4,5)P3 [21].
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